C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older - Wikidata - wikimedia - TriplyDB

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older

http://www.wikidata.org/entity/Q33759050

about

Detection of pleiotropy through a Phenome-wide association study (PheWAS) of epidemiologic data as part of the Environmental Architecture for Genes Linked to Environment (EAGLE) study.-174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race.Genetic variation across C-reactive protein and risk of prostate cancer.Association of interleukin-6 (-174 G/C) polymorphism with the prostate cancer risk: A meta-analysis.Genetic variation in RNASEL associated with prostate cancer risk and progression.The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis.Metabolic imbalance and prostate cancer progression.Inflammatory markers in population studies of aging.Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer.Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk.Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain.Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence Association of Plasma Heat Shock Protein 70, Interleukin 6, and Creatine Kinase Concentrations in a Healthy, Young Adult Population.Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis Inflammatory genetic markers of prostate cancer risk.Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study.High-sensitivity C-reactive protein and cancer.Quantitative analysis of the association between CRP rs2808630 and rs1417938 polymorphisms and cancer risk.Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies.Prediagnostic circulating markers of inflammation and risk of prostate cancer.Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation.Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis.The Pathologic Role of Toll-Like Receptor 4 in Prostate Cancer.Interleukin-6 promoter variants, prostate cancer risk, and survival Education, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer

P2860

Q30874310-F90C7F1E-5AFE-4B9D-B4C3-AA01516EF65D Q33684259-F29DC460-CD62-41E4-B1B8-2724E6EA65F8 Q33777217-03828FD7-8778-4DE7-8251-0447357651C4 Q33932481-EE009CFC-5D61-416F-97FB-A015035C80CA Q34094981-79474A86-EED2-44F8-9934-D5E98AFEBA5A Q34239802-61BCE9C9-5F6C-4951-A950-0A004BCAE967 Q34794028-0F5E226D-66BE-4A19-BFAF-EBA3C7EF29F3 Q34995451-AD727FA1-A661-4839-9E52-D74670ADBF43 Q35318562-0DE96C1E-73D4-442D-BF05-F8176EBE9972 Q35516448-99BA3675-3D71-49F6-8B49-3D68E39A3C50 Q36299394-D7A02C76-3B78-4777-A734-0E59C66D29E5 Q36306209-E8172257-991E-4930-8937-09200B51E534 Q36339558-48DE490D-4309-49AD-B2F2-05551264EB4B Q36486486-529F1D57-6676-4ADE-8338-D3F04BEEC126 Q36525733-06305627-FF88-4436-8CE9-BAE7443B837C Q37328413-17128F80-C436-40D1-9AC7-2B96CB26ECCA Q37332118-775F000D-DDB6-44FA-8758-B7F0F6D14E9F Q37506191-8F060622-063D-439A-8F20-0936EBE9BA42 Q42076173-13E507EF-2F62-48D4-8EC4-6BB91FB1103E Q42293538-FAC91428-DCAA-46D9-BD2E-5F0308F7D4DE Q43536797-560D2289-8C48-4B78-A1CB-A05BA3E7E451 Q44788547-5D9CE527-75F2-42CC-93E4-90FE50C53436 Q53149258-8A0E5B87-6D39-444F-8E7F-506C32CB3490 Q55195036-709CAFC8-878A-440A-B0F0-E0A68CBF9FEC Q55339148-988C8022-340C-4C76-B197-643405AEAE9E Q57265634-9CBF563E-C8B4-4484-9288-CD4FEAB3325D Q58857134-6D8D0AC2-D67F-42C2-A5A2-87EB1F3210E0

P2860

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older

http://www.wikidata.org/entity/Q33759050

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

C-reactive protein, interleuki ...... in men aged 65 years and older

@ast

C-reactive protein, interleuki ...... in men aged 65 years and older

@en

type

label

C-reactive protein, interleuki ...... in men aged 65 years and older

@ast

C-reactive protein, interleuki ...... in men aged 65 years and older

@en

prefLabel

C-reactive protein, interleuki ...... in men aged 65 years and older

@ast

C-reactive protein, interleuki ...... in men aged 65 years and older

@en

P1433

Q33759050-D704C309-C3AD-4B14-8BFB-C8D3EEA9E741

P1476

Q33759050-F15E2695-994B-4B8D-A65A-972CFD63EFBD

P2093

Q33759050-5EF78896-478C-46BF-B6FC-46B8B4CA70B1

Q33759050-5F22D32F-7BC3-4A80-AEC7-A318A6039B60

Q33759050-AFF87762-6EB4-43AA-AD11-63E906EF82E1

Q33759050-B9FD0C48-3999-4E9A-83F2-82B9D7BFC97D

Q33759050-BC3CE63E-0C2F-4F67-B0EA-DB37B099F7ED

Q33759050-C519B36A-3DA9-4527-856D-85FE61624A2E

Q33759050-D3FC9542-D881-4E47-A680-065D207BB9E5

Q33759050-FB8AEF38-B4FE-41F9-8E7A-037F80AC9699

P2860

Q33759050-09A06A77-BB84-476E-8845-B0774385E4BF

Q33759050-18A2B9EB-D52F-4D31-888A-474F753E7BBF

Q33759050-1A8C68FD-7030-43C8-BE58-303D587D0B3E

Q33759050-1B805C1D-B5A5-403B-9B89-56D2CD4950D3

Q33759050-23ED82B0-4CD2-4539-9BF1-D4A7FBAD9913

Q33759050-300A1F89-B416-4E8B-8433-6D4BB5E2C809

Q33759050-34D8EE08-9661-4C67-80FD-7EEE5B246FB3

Q33759050-41080DF5-97FA-418F-A378-B9204E069FD4

Q33759050-48F48B22-77DC-4C0A-A3DF-1D7E8D14B097

Q33759050-543B12AD-15E4-4422-B1A5-9787EFB74339

P2888

Q33759050-05CB75F8-CB05-4F9C-9658-37E828F05BE1

P304

Q33759050-F55C7F10-9848-41AA-A41F-40BFD9253DA2

P31

Q33759050-FA15D731-0A50-404B-AEBC-92F1A400F847

P356

Q33759050-E76263B8-6105-4895-9CA6-3285C034350E

P433

Q33759050-CC0950FF-6AC9-4F58-9497-00E6D113F1EF

P478

Q33759050-5661D37F-3BC5-470B-B90A-36871353F125

P50

Q33759050-6D668047-37DD-43B0-946C-6D46D8233314

P577

Q33759050-46335ED1-C41A-438F-9114-EEA5A36642B2

P5875

Q33759050-7BF96753-6D0A-411A-B2B8-922555397094

P698

Q33759050-C5265BBB-C6EB-4D67-BD57-F03F767F7E47

P932

Q33759050-E985E21E-985F-4FE9-AB93-315F85136BF0

P356

S10552-009-9320-4

P1433

Cancer Causes & Control

P1476

C-reactive protein, interleuki ...... in men aged 65 years and older

@en

P2093

Alexander P Reiner

http://www.w3.org/2001/XMLSchema#string

Annette Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

Christopher Li

http://www.w3.org/2001/XMLSchema#string

Christopher S Carlson

http://www.w3.org/2001/XMLSchema#string

Janet L Stanford

http://www.w3.org/2001/XMLSchema#string

Marvalyn DeCambre

http://www.w3.org/2001/XMLSchema#string

Mary L Biggs

http://www.w3.org/2001/XMLSchema#string

Melissa A Austin

http://www.w3.org/2001/XMLSchema#string

P2860

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Innate immunity and inflammation in ageing: a key for understanding age-related diseases

The Cardiovascular Health Study: design and rationale

Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels.

Meta-analysis of measures of sexual activity and prostate cancer.

Epidemiologic association between prostatitis and prostate cancer.

Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.

Epidemiology of inflammation and prostate cancer.

The complex genetic epidemiology of prostate cancer.

Inflammation in prostate carcinogenesis.

P2888

s10552-009-9320-4

P304

1193-1203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10552-009-9320-4

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24182980

http://www.w3.org/2001/XMLSchema#string

P698

19267250

http://www.w3.org/2001/XMLSchema#string

P932

2846958

http://www.w3.org/2001/XMLSchema#string